You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API AZELASTINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing AZELASTINE HYDROCHLORIDE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Wallace Pharmaceuticals Inc AZELASTINE HYDROCHLORIDE azelastine hydrochloride 51525-0234 BENZALKONIUM CHLORIDE
Wallace Pharmaceuticals Inc AZELASTINE HYDROCHLORIDE azelastine hydrochloride 51525-0234 EDETATE DISODIUM
Wallace Pharmaceuticals Inc AZELASTINE HYDROCHLORIDE azelastine hydrochloride 51525-0234 HYPROMELLOSE
Wallace Pharmaceuticals Inc AZELASTINE HYDROCHLORIDE azelastine hydrochloride 51525-0234 SODIUM CITRATE
Wallace Pharmaceuticals Inc AZELASTINE HYDROCHLORIDE azelastine hydrochloride 51525-0234 SORBITOL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing AZELASTINE HYDROCHLORIDE

Company Ingredient NDC Excipient
West-Ward Pharmaceuticals Corp azelastine hydrochloride 0054-0293 ANHYDROUS CITRIC ACID
West-Ward Pharmaceuticals Corp azelastine hydrochloride 0054-0293 BENZALKONIUM CHLORIDE
West-Ward Pharmaceuticals Corp azelastine hydrochloride 0054-0293 EDETATE DISODIUM
West-Ward Pharmaceuticals Corp azelastine hydrochloride 0054-0293 HYPROMELLOSE
West-Ward Pharmaceuticals Corp azelastine hydrochloride 0054-0293 SODIUM CHLORIDE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for AZELASTINE HYDROCHLORIDE

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: BENZALKONIUM CHLORIDE

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

AZELASTINE HYDROCHLORIDE drug variants containing CARBOXYMETHYLCELLULOSE SODIUM

Company Ingredient NDC
Meda Pharmaceuticals Inc azelastine hydrochloride and fluticasone propionate 0037-0245
Mylan Pharmaceuticals Inc azelastine hydrochloride and fluticasone propionate 0378-3458
Padagis Israel Pharmaceuticals Ltd azelastine hydrochloride, fluticasone propionate 45802-066
Bryant Ranch Prepack azelastine hydrochloride, fluticasone propionate 63629-8612
Bryant Ranch Prepack azelastine hydrochloride, fluticasone propionate 72162-1388
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: CELLULOSE, MICROCRYSTALLINE

AZELASTINE HYDROCHLORIDE drug variants containing CELLULOSE, MICROCRYSTALLINE

Company Ingredient NDC
Meda Pharmaceuticals Inc azelastine hydrochloride and fluticasone propionate 0037-0245
Mylan Pharmaceuticals Inc azelastine hydrochloride and fluticasone propionate 0378-3458
Padagis Israel Pharmaceuticals Ltd azelastine hydrochloride, fluticasone propionate 45802-066
Bryant Ranch Prepack azelastine hydrochloride, fluticasone propionate 63629-8612
Bryant Ranch Prepack azelastine hydrochloride, fluticasone propionate 72162-1388
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: EDETATE DISODIUM

Excipient focus: GLYCERIN

AZELASTINE HYDROCHLORIDE drug variants containing GLYCERIN

Company Ingredient NDC
Meda Pharmaceuticals Inc azelastine hydrochloride and fluticasone propionate 0037-0245
Mylan Pharmaceuticals Inc azelastine hydrochloride and fluticasone propionate 0378-3458
Padagis Israel Pharmaceuticals Ltd azelastine hydrochloride, fluticasone propionate 45802-066
Bryant Ranch Prepack azelastine hydrochloride, fluticasone propionate 63629-8612
Bryant Ranch Prepack azelastine hydrochloride, fluticasone propionate 72162-1388
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2906

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: PHENYLETHYL ALCOHOL

AZELASTINE HYDROCHLORIDE drug variants containing PHENYLETHYL ALCOHOL

Company Ingredient NDC
Meda Pharmaceuticals Inc azelastine hydrochloride and fluticasone propionate 0037-0245
Mylan Pharmaceuticals Inc azelastine hydrochloride and fluticasone propionate 0378-3458
Padagis Israel Pharmaceuticals Ltd azelastine hydrochloride, fluticasone propionate 45802-066
Bryant Ranch Prepack azelastine hydrochloride, fluticasone propionate 63629-8612
Bryant Ranch Prepack azelastine hydrochloride, fluticasone propionate 72162-1388
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: POLYSORBATE 80

AZELASTINE HYDROCHLORIDE drug variants containing POLYSORBATE 80

Company Ingredient NDC
Meda Pharmaceuticals Inc azelastine hydrochloride and fluticasone propionate 0037-0245
Mylan Pharmaceuticals Inc azelastine hydrochloride and fluticasone propionate 0378-3458
Padagis Israel Pharmaceuticals Ltd azelastine hydrochloride, fluticasone propionate 45802-066
Bryant Ranch Prepack azelastine hydrochloride, fluticasone propionate 63629-8612
Bryant Ranch Prepack azelastine hydrochloride, fluticasone propionate 72162-1388
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM PHOSPHATE, DIBASIC

Excipient focus: SODIUM PHOSPHATE, DIBASIC DODECAHYDRATE

Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE

Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

Excipient focus: SORBITOL

Excipient focus: SUCRALOSE

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group